BrainChild Bio, Inc: Clinical Trials

1 trial sponsored by BrainChild Bio, Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow BrainChild Bio, Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
BCB-276 - Diffuse Intrinsic Pontine Glioma, DIPG
Phase 2RecruitingBrainChild Bio, Inc752026-09-042026-10-28

Conditions studied

Brain Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Neoplasms (1)

Countries

United States (1)

Top investigators

Cori Abikoff, MD (1)